AQST
Aquestive Therapeutics, Inc.$3.77CS band Caution
+$0.11 (2.92%) At close $3.88 · Today
☾After Hours −$0.11 (2.81%) Nov 3, 7:59 PM ET
About AQST
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.